Home » Newsletters » BioWorld Science

BioWorld Science

April 30, 2001

View Archived Issues

Patient recruitment complete in Cangene's three phase III trials

Ophidian updates merger plan with Hemoxymed

SkyePharma summarizes major achievements over past year

NeoTherapeutics receives U.S. patent for technology with broad therapeutic applications

Vertex reports Q1 2001 results

Antiparkinsonian A-7 blocks open NMDA channels similar to adamantane

PhotoCure seeks marketing approval for Metvix(R) PDT in New Zealand

GlaxoSmithKline Biologics and MVI to initiate pediatric clinical trial of malaria vaccine

Aventis prepares oxindoles as potent inhibitors of cyclin-dependent kinases

Vasogen plans trial of immune modulation therapy for PAD

Medarex and Neuro Therapeutics enter alliance to develop antibody therapeutics

ImClone Systems achieves milestone in BEC2 collaboration with Merck KGaA

Scios updates status, reviews progress of lead products

MX-2060: a novel caspase-activating apoptosis inducer discovered at Maxim

Avant Immunotherapeutics reports highlights for the quarter

IntaBiotics' Protegrin IB-367 rinse meets secondary but not primary endpoints

Progenics and Roche extend HIV therapeutics collaboration

3-D Pharmaceuticals and Boehringer Ingelheim extend drug discovery collaboration

Forbes Medi-Tech provides additional preclinical study results for FM-VP4

Organogenesis provides brief product update

Lilly claims new use of parathyroid hormone

Direct delivery of bFGF shown to be useful in wound healing model

New endothelin receptor antagonists useful for circulatory disorders

New compounds interacting with estrogen receptors useful for menopausal disorders, etc.

Aventis presents new NHE-3 inhibitors

New 5-HT6 receptor modulators useful for CNS disorders patented by Pharmacia

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 20, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...
Novel caspase-2 inhibitor shows in vivo neuroprotective effects
BioWorld Science
Caspase-2-mediated cleavage of tau at Asp314 generates a neurotoxic fragment, Δtau314, that drives early synaptic dysfunction in Alzheimer’s disease (AD) and...